Mark Leonard Singleton - Apr 4, 2022 Form 4 Insider Report for Bioventus Inc. (BVS)

Role
SVP & CFO
Signature
/s/ Anthony D'Adamio, Attorney-in-Fact
Stock symbol
BVS
Transactions as of
Apr 4, 2022
Transactions value $
$0
Form type
4
Date filed
4/5/2022, 09:06 PM
Previous filing
Mar 25, 2022
Next filing
Mar 23, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BVS Restricted Stock Units Award $0 +74.5K $0.00 74.5K Apr 4, 2022 Class A Common Stock 74.5K Direct F1, F2
transaction BVS Stock Option (Right to Buy) Award $0 +223K $0.00 223K Apr 4, 2022 Class A Common Stock 223K $13.29 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2 The restricted stock units and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 21, 2022, in each case subject to the Reporting Person continuing in service through the applicable vesting date.